N/A N=16 Blood Flow Restriction Training in Individuals Awaiting Total Knee Replacement
Knee Osteoarthritis
Primary: Quadricep Muscle Strength — 86.15; 76.55; 91.03; 80.32 torque newton-meter
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=11 Analyzing Preoperative Stereotactic Radiosurgery With Gamma Knife Icon for Brain Metastases
Brain Metastases
Primary: The Number of Subjects Undergoing Resection Following SRS. — 11 Participants
Phase 3 N=2,410 FLuorometholone as Adjunctive MEdical Therapy for TT Surgery (FLAME) Trial
Trachomatous Trichiasis (TT) · Eye Diseases · Eyelid Diseases
Primary: Incidence of Postoperative TT by One Year, as Determined by Trained Study Team Members — 218; 213; 32; 36 Study eyes — p=0.97
Phase 2 N=202 D-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection
Abdominal Surgery · Colon Surgery · Post-Op Infection
Primary: The Combined Infection and Mortality Rate Within 30 Days Post Index Surgery — 24; 10 Participants — p=0.0086
Phase 4 N=64 Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action
Chronic Migraine
Primary: Change in Gray Matter Thickness in the Somatosensory Cortex — -0.043; 0 mm
N/A N=200 Bacteria in Atherosclerotic Plaques and Adverse Events
Carotid Artery Stenosis · Cerebral Infarction · Diabetes
Primary: Analysis of Bacterial Types in Plaques — 2.2; 0.58 percentage
N/A N=48 Mobile Video Education to Improve Patient Clinician Communication During Prenatal Clinic Visits
Patient Empowerment
Primary: Parents' Communication Behaviors Measure — 58; 55 Percentage of behavior items reported
Phase 3 N=97 Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease
Fabry Disease
Primary: Number of Participants With Treatment-related Adverse Events — 46; 8; 6; 5 Participants
N/A N=40 Sleep Goal-focused Online Access to Lifestyle Support
Weight Loss · Weight, Body
Primary: Recruitment - Number of the Total Sample — 40 Participants
Phase 1 N=21 Effect of Bismuth Subsalicylate on the Gut Microbiome and Host Response in Healthy Adults
Healthy Adults
Primary: To Evaluate the Effect of BSS on the Human Gut Microbiome. — 2 Number of different bacterial taxa — p=<0.05
Phase 2 N=229 Study to Evaluate ARO-APOC3 in Adults With Severe Hypertriglyceridemia
Severe Hypertriglyceridemia
Primary: Percent Change From Baseline at Week 24 in Fasting Triglycerides (TG) — -17.2; -66.0; -70.2; -74.2 percentage change — p=< 0.0001
Phase 4 N=95 Aggravated Airway Inflammation: Research on Biological Treatment (Mepolizumab)
Asthma, Aspirin-Induced · Chronic Rhinosinusitis With Nasal Polyps
Primary: Change From Baseline at Week 16 in Sinonasal Outcome Test -22 (SNOT-22) Score — -14.09; -4.37 points
N/A N=14 Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery
Skin Laxity · Tissue Degeneration · Tissue Breakdown
Primary: Analysis of Elasticity (Collagen & Elastin) — 1.7; 0.5; 1.5; 0.5 units on a scale
Phase 1 N=25 Personalized Immunotherapy in Adults With Advanced Cancers Immunotherapy in Adults With Advanced Cancers
Advanced Cancer
Primary: Treatment-related Adverse Events — 19; 103; 85 Number of Treatment-related Adverse Even
N/A N=252 Community Support Program for Lung Cancer Screening Volume II
Lung Cancer
Primary: Scheduled Lung Cancer Screening Appointments Attended by Participants — 21; 65; 59 Participants